Serum cholesterol and low-density lipoprotein cholesterol levels as predictors of response to interferon therapy for chronic hepatitis C

被引：28
|
作者：
Minuk, GY [1 ]
Weinstein, S [1 ]
Kaita, KD [1 ]
机构：
[1] Univ Manitoba, Winnipeg, MB R3E 1R9, Canada
来源：
ANNALS OF INTERNAL MEDICINE | 2000年 / 132卷 / 09期
关键词：
D O I：
10.7326/0003-4819-132-9-200005020-00023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：761 / 762
页数：2
相关论文
共 50 条
  • [1] Interferon-lambda Genotype and Low Serum Low-Density Lipoprotein Cholesterol Levels in Patients with Chronic Hepatitis C Infection
    Li, Josephine H.
    Lao, Xiang Qian
    Tillmann, Hans L.
    Rowell, Jennifer
    Patel, Keyur
    Thompson, Alexander
    Suchindran, Sunil
    Muir, Andrew J.
    Guyton, John R.
    Gardner, Stephen D.
    McHutchison, John G.
    McCarthy, Jeanette J.
    HEPATOLOGY, 2010, 51 (06) : 1904 - 1911
  • [2] Cholesterol and lipoprotein levels as predictors of response to interferon far hepatitis C
    Toyoda, H
    Kumada, T
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 921 - 921
  • [3] Statin Therapy in Patients With Low Serum Levels of Low-Density Lipoprotein Cholesterol
    Tsujimoto, Tetsuro
    Kajio, Hiroshi
    Sugiyama, Takehiro
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (11): : 1947 - 1954
  • [4] Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients
    del Valle, Jose
    Mira, Jose A.
    de los Santos, Ignacio
    Lopez-Cortes, Luis F.
    Merino, Dolores
    Rivero, Antonio
    Giron, Jose A.
    Rios-Villegas, Maria J.
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Garcia-Garcia, Jose A.
    Pineda, Juan A.
    AIDS, 2008, 22 (08) : 923 - 930
  • [5] IMPACT OF THE LOW-DENSITY LIPOPROTEIN CHOLESTEROL ON RESPONSE TO TELAPREVIR-BASED TRIPLE THERAPY FOR CHRONIC HEPATITIS C PATIENTS
    Ogawa, E.
    Furusyo, N.
    Nakamuta, M.
    Kajiwara, E.
    Nomura, H.
    Dohmen, K.
    Takahashi, K.
    Satoh, T.
    Azuma, K.
    Kawano, A.
    Tanabe, Y.
    Kotoh, K.
    Shimoda, S.
    Hayashi, J.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S445 - S446
  • [6] Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment
    Lahoz, C
    Peña, R
    Mostaza, JM
    Laguna, F
    García-Iglesias, MF
    Taboada, M
    Pintó, X
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (06): : 741 - 747
  • [7] Statins and low-density lipoprotein cholesterol levels
    Cohen, JS
    AMERICAN JOURNAL OF MEDICINE, 2003, 115 (01): : 74 - 75
  • [8] Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment
    Hashimoto, Satoru
    Yatsuhashi, Hiroshi
    Abiru, Seigo
    Yamasaki, Kazumi
    Komori, Atsumasa
    Nagaoka, Shinya
    Seeki, Akira
    Uchida, Shinjiro
    Bekki, Shigemune
    Kugiyama, Yuki
    Nagata, Kazuyoshi
    Nakamura, Minoru
    Migita, Kiyoshi
    Nakao, Kazuhiko
    PLOS ONE, 2016, 11 (09):
  • [9] Effects of Dapagliflozin on Serum Low-Density Lipoprotein Cholesterol and Triglyceride Levels
    Gurkan, Eren
    EUROPEAN JOURNAL OF THERAPEUTICS, 2020, 26 (01): : 76 - 80
  • [10] Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
    Adami, S
    Braga, V
    Guidi, G
    Gatti, D
    Gerardi, D
    Fracassi, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (03) : 599 - 604
12345